全球领先的新经济产业第三方数据挖掘与分析机构
关于“数字医疗”的报告
艾媒咨询 | 2025年中国数字健康管理行业发展状况与用户行为调查数据
在技术革新与健康意识觉醒的双重驱动下，中国数字健康管理行业进入高速发展期。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国数字健康管理行业发展状况与用户行为调查数据》数据显示，2024年中国体检市场规模为2374.3亿元，中国体检行业市场规模呈现稳定增长态势。在2025年中国健康管理平台用户使用健康管理类App原因中，改善睡眠质量的占比最高，达到63.57%；体型管理和促进肠道健康的占比分别位列第二和第三，分别为44.30%和40.09%。这说明睡眠质量、体型管理和肠道健康是健康管理平台用户使用健康管理App的主要原因。在2025年中国健康管理平台用户认为影响选择App的因素中，食物营养管理分析以46.73%的比例成为最突出的因素，显示出健康管理平台用户对营养管理的高度重视。其次，有免费的健身课程占比41.20%，有比较优惠的健身课程占比39.31%，显示出健康管理平台用户对健康管理App的功能性和实用性有较高要求。艾媒咨询分析师认为，未来中国数字健康管理行业将呈现三大趋势：技术上，AI诊断、可穿戴设备与 5G 远程监测加速落地，推动健康管理精准化；场景上，家庭健康监测、企业健康管理、社区养老服务等成为新增长点；生态上，“数字健康+保险+医疗” 跨界融合模式成熟，通过数据共享实现多方共赢。企业需聚焦用户体验与技术合规，在政策支持与消费需求驱动下，构建更具竞争力的数字健康生态。
Driven by both technological innovation and the awakening of health awareness, China's digital health management industry has entered a period of rapid development. According to the latest "Survey data on the development status and user behavior of China's digital health management industry in 2025" released by iiMedia Research, a world-leading third-party data mining and analysis institution for the new economy industry, the market size of China's physical examination industry shows a stable growth trend. The market size of physical examinations was 46.83 billion yuan in 2012, increasing to 59.26 billion yuan in 2013. Since then, it has been steadily growing every year, reaching 225.05 billion yuan in 2023 and climbing to 237.43 billion yuan in 2024. In the future, with the continuous enhancement of people's health awareness, the improvement of consumption capacity and the advancement of medical technology, the demand for physical examinations will continue to be released. The market size of China's physical examination industry is expected to maintain a growth trend in the future. Among the reasons why users of health management platforms in China used health management apps in 2025, the proportion of improving sleep quality was the highest, reaching 63.57%. The proportions of body shape management and promoting intestinal health ranked second and third respectively, being 44.30% and 40.09% respectively.This indicates that sleep quality, body shape management and intestinal health are the main reasons why users of health management platforms use health management apps. In 2025, among the factors that Chinese health management platform users believed influenced their choice of apps, the analysis of food nutrition management accounted for 46.73%, becoming the most prominent factor, demonstrating the high attention that health management platform users attach to nutrition management. Secondly, the proportion of free fitness courses is 41.20%, and the proportion of relatively favorable fitness courses is 39.31%, indicating that users of the health management platform have high requirements for the functionality and practicality of the health management App. Analysts from iiMedia Research believe that the industry will present three major trends in the future: Technically, AI diagnosis, wearable devices and 5G remote monitoring are accelerating their implementation, promoting the precision of health management; In terms of scenarios, family health monitoring, enterprise health management, and community elderly care services have become new growth points. Ecologically, the cross-border integration model of "digital health + insurance + medical care" is mature, achieving a win-win situation for all parties through data sharing. Enterprises need to focus on user experience and technical compliance, and build a more competitive digital health ecosystem driven by policy support and consumer demand.-
-
艾媒咨询 | 2025年中国医用分子筛制氧行业发展白皮书
需求增长驱动医用分子筛制氧市场扩容，技术创新将推动行业向智能化、绿色化、高端化迈进。iiMedia Research（艾媒咨询）数据显示，2024年中国医用分子筛制氧机市场规模约4.25亿元，预计2029年将进一步攀升至7.06亿元。随着人口老龄化的加剧、公众健康意识的提高，以及医疗需求的增加，中国医用分子筛制氧机市场的规模在稳步扩大。同时，国家对医疗健康产业的重视程度不断提升，加之环保和新能源等领域的发展，医用分子筛制氧机在工业、医疗和家用等多个领域的应用正不断拓展。
Demand growth drives the expansion of the medical molecular sieve oxygen production market, and technological innovation will promote the industry to become intelligent, green and high-end. iiMedia Research data show that in 2024, the market size of China's medical molecular sieve oxygen generator is about 425 million yuan, and it is expected to further climb to 706 million yuan in 2029. With the increasing aging of the population, the improvement of public health awareness and the increase of medical demand, the scale of China's medical molecular sieve oxygen generator market is steadily expanding. At the same time, the state's attention to the medical and health industry continues to improve, coupled with the development of environmental protection and new energy and other fields, medical molecular sieve oxygen generator in industrial, medical and household applications are constantly expanding. -
-
艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告
本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康
数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry. -
-
-
-
艾媒咨询|2021年中国轻医美行业研究及产业链分析报告
本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物
数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization. -
- 1
- 2
- 3
- 4
- 5
- 6
- 81
